Laparoscopic surgery for gynaecomastia is a term frequently searched by men exploring treatment for enlarged male breast tissue, yet it is important to understand what surgical options genuinely exist. Gynaecomastia — the benign enlargement of glandular breast tissue in males — affects men across all age groups and can cause significant physical discomfort and psychological distress. This article explains when surgery is appropriate, which techniques are actually used in UK practice, what to expect from the procedure and recovery, and how to choose a safe, regulated provider whether you are seeking NHS or private treatment.

What Is Gynaecomastia and When Is Surgery Considered?

Gynaecomastia is benign glandular breast enlargement in males caused by an oestrogen–androgen imbalance; surgery is considered when the condition persists beyond two years, causes significant distress, or fails to respond to conservative management.

Gynaecomastia refers to the benign enlargement of glandular breast tissue in males, affecting one or both breasts. It is a relatively common condition, occurring across all age groups but particularly during puberty, middle age, and later life. The condition arises from an imbalance between oestrogen and androgen activity in breast tissue, leading to ductal and stromal proliferation. It is distinct from pseudogynaecomastia, which involves fatty tissue accumulation without true glandular enlargement.

Common underlying causes include:

• Hormonal changes during puberty or ageing

• Medications such as spironolactone, anabolic steroids, antipsychotics, and some antihypertensives

• Medical conditions including hypogonadism, liver cirrhosis, hyperthyroidism, and renal failure

• Recreational drug use, including cannabis and alcohol

When to seek urgent assessment — red flag features Although gynaecomastia is usually benign, certain features require urgent referral to a breast clinic under the NHS 2-week-wait pathway (in line with NICE NG12: Suspected Cancer: Recognition and Referral). Men should be referred urgently if they present with:

• A unilateral, firm or hard subareolar mass, particularly in men aged 50 or over

• Nipple discharge, retraction, or skin changes

• Axillary lymphadenopathy

• Any breast lump with features suspicious of malignancy

These features must be excluded before gynaecomastia is attributed to a benign cause.

Initial assessment A thorough clinical assessment should precede any surgical referral and typically includes:

• A detailed medication and substance history (including anabolic steroids, cannabis, and alcohol)

• Physical examination, including assessment of the testes for masses or atrophy

• Blood tests: testosterone, LH, FSH, oestradiol, hCG, prolactin, TSH, and liver and renal function

• Targeted imaging: breast imaging if the mass has atypical features; testicular ultrasound if a testicular mass is found or hCG/oestradiol is elevated

Referral to endocrinology or urology should be considered where hypogonadism, abnormal tumour markers, or conditions such as Klinefelter syndrome are suspected.

Conservative and medical management In many cases, particularly in adolescents, gynaecomastia resolves spontaneously within one to two years. The first step is to identify and address any reversible underlying cause — for example, stopping or substituting a causative medication. Where the condition is recent, painful, and persistent despite addressing the underlying cause, a short course of tamoxifen may be considered by a specialist; however, this use is off-label and should be accompanied by appropriate safety counselling. The evidence for medical therapy is limited, and it is not routinely recommended.

Surgery is typically considered when the condition persists beyond two years, causes significant psychological distress, results in physical discomfort, or fails to respond to conservative management. Patients should be counselled that surgery is not routinely available on the NHS and is generally reserved for cases with demonstrable clinical or psychological need.

Surgical Options for Gynaecomastia on the NHS and Privately

Surgical options include subcutaneous mastectomy, liposuction, or a combined approach; NHS access requires evidence of clinical or psychological need, while most UK patients access treatment privately through GMC-registered, CQC-regulated surgeons.

Surgical treatment for gynaecomastia encompasses several techniques, and the most appropriate approach depends on the grade of the condition, the ratio of glandular to fatty tissue, and the degree of skin excess. The most widely used classification is the Simon grading system, which ranges from Grade I (minor enlargement without skin redundancy) to Grade IIb and Grade III (marked enlargement with significant skin excess).

The principal surgical options include:

• Subcutaneous mastectomy — surgical excision of glandular tissue via a periareolar or inframammary incision

• Liposuction — used primarily where fatty tissue predominates; liposuction alone may not adequately remove firm glandular tissue

• Combined excision and liposuction — the most commonly employed approach in clinical practice

• Skin reduction procedures — reserved for Grade III cases with significant ptosis

Excised tissue is routinely sent for histopathological examination, particularly where any atypical features are present.

NHS access Surgical correction on the NHS is subject to local Integrated Care Board (ICB) commissioning criteria, which vary across England. Funding is not routinely granted and typically requires evidence of significant clinical or psychological need. Where standard criteria are not met, patients may apply through an Individual Funding Request (IFR) process. Patients are advised to check their local ICB policy and discuss eligibility with their GP. Equivalent processes apply in Wales, Scotland, and Northern Ireland under their respective health systems.

Private treatment Most patients in the UK access treatment through private healthcare providers. Costs vary depending on the technique used, the surgeon's experience, and the facility. Patients seeking private treatment should verify that their surgeon:

• Is registered with the General Medical Council (GMC) and listed on the GMC Specialist Register in Plastic Surgery

• Practises at a provider regulated by the Care Quality Commission (CQC) in England, or the equivalent regulator in their nation (Healthcare Inspectorate Wales, Healthcare Improvement Scotland, or the Regulation and Quality Improvement Authority in Northern Ireland)

• Holds membership of BAAPS (British Association of Aesthetic Plastic Surgeons) or BAPRAS (British Association of Plastic, Reconstructive and Aesthetic Surgeons), which can serve as an additional quality marker

A thorough pre-operative consultation, including discussion of realistic outcomes, potential risks, and the possibility of revision surgery, is essential before proceeding.

How Endoscope-Assisted and Minimally Invasive Techniques Are Used in Gynaecomastia Surgery

Traditional laparoscopy is not used for gynaecomastia; endoscope-assisted subcutaneous mastectomy (EASM) and energy-assisted liposuction are minimally invasive alternatives, but both have limited evidence and are not yet standard UK practice.

It is important to clarify that traditional laparoscopic (keyhole) surgery, as used in abdominal procedures such as cholecystectomy or appendicectomy, is not applicable to gynaecomastia correction. Laparoscopy involves working within a gas-inflated abdominal cavity and has no role in chest wall or breast surgery. The term 'laparoscopic surgery for gynaecomastia' is sometimes encountered in patient searches, but there is no clinical framework in the UK that defines laparoscopy as a modality for this condition.

Endoscope-assisted subcutaneous techniques Minimally invasive principles do underpin some contemporary approaches. Endoscope-assisted subcutaneous mastectomy (EASM) — sometimes called video-assisted gynaecomastia surgery — uses a small camera to visualise and excise glandular tissue through smaller incisions than conventional open surgery. These techniques have been explored in specialist centres and are distinct from laparoscopy, as they operate in the subcutaneous plane of the chest wall rather than within a body cavity.

The potential advantages cited include reduced visible scarring and improved visualisation; however, the evidence base remains limited, consisting largely of case series rather than robust comparative trials. These techniques are not yet considered standard practice across UK surgical units, and claimed benefits should be regarded as centre-specific rather than established. Patients considering such approaches should seek treatment from experienced surgeons who can clearly explain the rationale, expected outcomes, and any additional risks.

Energy-assisted liposuction Ultrasound-assisted liposuction (UAL) and laser-assisted liposuction represent minimally invasive adjuncts that emulsify fatty and fibrous tissue before aspiration. These may be useful where dense fibroglandular tissue makes conventional liposuction less effective. However, the evidence for superiority over conventional liposuction is limited and results are operator-dependent. Specific risks associated with energy-assisted techniques include thermal injury to surrounding tissue, contour irregularities, seroma formation, and nerve injury. Any devices used should be MHRA-compliant.

Standard UK practice remains open or mini-incision excision with or without conventional liposuction. Transparency about technique selection — including its evidence base — is a key component of informed consent.

What to Expect Before, During, and After the Procedure

Most gynaecomastia surgery is performed under general anaesthesia via a periareolar incision, taking one to two hours; patients should wear a compression garment for four to six weeks and avoid strenuous activity for at least four weeks post-operatively.

Before surgery Patients will undergo a comprehensive pre-operative assessment, including a review of medical history, current medications, and any relevant blood tests or imaging. Patients are advised to stop smoking at least six weeks prior to surgery, as smoking significantly impairs wound healing and increases anaesthetic risk.

Certain medications — including aspirin, non-steroidal anti-inflammatory drugs (NSAIDs), and herbal supplements — may need to be paused to reduce bleeding risk. However, patients must not stop prescribed anticoagulants or antiplatelet agents without first discussing a peri-operative management plan with their surgical or anaesthetic team. A pre-operative consultation with the anaesthetist is standard practice; the Royal College of Anaesthetists provides patient information on what to expect.

A formal VTE (venous thromboembolism) risk assessment should be completed before surgery, in line with NICE NG89, and appropriate prophylaxis arranged where indicated.

During the procedure Most gynaecomastia surgeries are performed under general anaesthesia, though local anaesthesia with sedation may be appropriate for minor cases. The duration varies from approximately one to two hours depending on the technique employed. Where excision is performed, the surgeon typically makes a periareolar incision (around the lower edge of the areola) to minimise visible scarring. Liposuction, if used, involves small stab incisions through which a cannula is inserted. Drains may be placed at the surgeon's discretion and are usually removed within the first day or two.

Immediately after surgery Patients are monitored in a recovery area before being discharged, usually on the same day. Patients must not drive or operate machinery for at least 24–48 hours after general anaesthesia or sedation, and not until they are able to perform an emergency stop safely. Key post-operative instructions include:

• Wearing a compression garment for four to six weeks to reduce swelling and support healing

• Avoiding strenuous activity and heavy lifting for at least four weeks

• Keeping wounds clean and dry as directed by the surgical team

• Early mobilisation to reduce VTE risk, in line with NICE NG89

• Attending follow-up appointments to monitor healing and assess results

Mild bruising, swelling, and temporary numbness around the nipple-areola complex are expected and typically resolve within several weeks. Individual recovery timelines vary; patients should follow the personalised advice given by their surgical team.

Risks, Complications, and MHRA Safety Considerations

Common risks include bruising, asymmetry, scarring, and altered nipple sensation; serious complications such as skin necrosis, DVT, or infection are less common and should be reported to the surgical team or, in an emergency, via 999.

As with all surgical procedures, gynaecomastia surgery carries a range of potential risks, which should be thoroughly discussed during the informed consent process. Patients should feel empowered to ask questions and should not proceed until they fully understand both the benefits and limitations of the procedure, including the possibility of revision surgery.

Common risks include:

• Bruising, swelling, and temporary discomfort

• Asymmetry between the two sides

• Changes in nipple or skin sensation, which may be temporary or permanent

• Visible scarring, particularly with open excision techniques

• Hypertrophic or keloid scarring, depending on individual healing

• Altered nipple position, shape, or pigmentation

• Seroma (fluid accumulation) or haematoma formation

Less common but more serious complications include:

• Infection requiring antibiotic treatment or surgical drainage

• Skin necrosis or partial/complete nipple-areolar necrosis, particularly in patients who smoke

• Contour irregularities or over-resection leading to a concave chest appearance

• Under-correction or recurrence requiring revision surgery

• Deep vein thrombosis (DVT) or pulmonary embolism, particularly with longer procedures

MHRA safety considerations The Medicines and Healthcare products Regulatory Agency (MHRA) oversees the safety of medicines, anaesthetic agents, and medical devices used in surgical procedures, including liposuction equipment. Patients and clinicians are encouraged to report suspected adverse effects related to medicines, anaesthetic agents, or medical devices via the MHRA Yellow Card scheme (available at yellowcard.mhra.gov.uk). The Yellow Card scheme is intended for reporting suspected adverse reactions to medicines and problems with medical devices — it is not a mechanism for reporting routine surgical complications, which should be raised directly with the surgical team or through the provider's complaints process.

Experiencing these side effects? Our pharmacists can help you navigate them →

When to seek help Patients should contact their surgical team promptly if they experience signs of infection (increasing redness, warmth, swelling, or discharge), sudden or worsening pain, or any unexpected change in their wound. If the surgical team is unavailable, contact NHS 111. Call 999 or go to the nearest emergency department immediately if symptoms suggest a blood clot, such as calf pain, sudden leg swelling, breathlessness, or chest pain. Early intervention significantly improves outcomes in the event of complications.

Recovery, Results, and Follow-Up Care in the UK

Most patients return to desk-based work within one to two weeks, with full recovery and scar maturation taking up to twelve months; results are generally long-lasting provided the underlying hormonal cause has been addressed.

Recovery from gynaecomastia surgery is generally well tolerated, with most patients returning to desk-based work within one to two weeks. Physical labour or exercise involving the upper body should be avoided for a minimum of four weeks, and full recovery — including resolution of swelling and final scar maturation — may take up to six to twelve months. It is important that patients maintain realistic expectations, as final results are not immediately apparent.

Follow-up care Reputable UK surgeons and clinics will schedule post-operative appointments at intervals such as approximately one week, six weeks, three months, and one year, though the precise schedule will vary by provider and individual need. Patients should confirm their agreed follow-up plan before discharge. These appointments allow the surgical team to:

• Monitor wound healing and identify early complications

• Assess symmetry and contour outcomes

• Provide scar management advice — for example, silicone gel or silicone sheeting applied once wounds have fully healed, and sun protection over scars for at least 12 months to minimise pigmentation changes

• Address any psychological concerns related to body image

Results and recurrence The results of gynaecomastia surgery are generally long-lasting, provided the underlying cause has been addressed. Recurrence is uncommon but can occur if hormonal imbalances persist or if anabolic steroid use continues. Patients should be counselled to maintain a stable weight, as significant weight gain may affect the aesthetic outcome.

Not sure if this is normal? Chat with one of our pharmacists →

Choosing and checking your provider For those treated on the NHS, follow-up is typically provided within the referring trust. Private patients should confirm the extent of aftercare included in their surgical package before proceeding, as standards vary between providers. Independent healthcare providers are regulated across the UK as follows:

• England: Care Quality Commission (CQC) — cqc.org.uk

• Wales: Healthcare Inspectorate Wales (HIW) — hiw.org.uk

• Scotland: Healthcare Improvement Scotland (HIS) — healthcareimprovementscotland.org

• Northern Ireland: Regulation and Quality Improvement Authority (RQIA) — rqia.org.uk

Patients can check a provider's registration status on the relevant regulator's website. If at any point a patient has concerns about their recovery or outcome, they should contact their GP or surgical team. If the surgical team is unavailable, NHS 111 can provide guidance; call 999 in an emergency.

Frequently Asked Questions